Updated corporate presentation
Faron Pharmaceuticals Oy (“Faron” or the “Company”) Updated corporate presentation Company announcement, 22 June 2021 at 9.00 AM (EEST) TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, has today published an updated corporate presentation on its website. The presentation contains previously published Company information, views of Management and data from Faron’s development programmes. Latest available data from the ongoing PhI/II MATINS trial investigating bexmarilimab, Faron's wholly-owned novel